ADP-A2M4CD8,Nivolumab
adaptimmune therapeutics,bms
['a2m4cd8', 'adp-a2m4']
adp-a2m4cd8 shows promising activity across mage-a4+ unresectable or metastatic tumor types #esmo2022 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.